Animal Health

PetMed Express is set to reveal its annual performance, but a year of steep losses, internal probes, and fierce competition has set a somber stage.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

A local dog walking company and Richmond's shelter created a partnership that gets nearly every participating dog a home. Here's how they did it.

For 20 years, a Bahamian resort has quietly built a conservation powerhouse. Inside its mission to rescue turtles, grow coral, and redefine tourism.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

French biotech TreeFrog Therapeutics isn't just replacing cells; it's implanting pre-wired networks. Their novel 3D microtissue shows faster, more extensive brain repair.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

A chilling short film and its unsettling LA ad campaign use psychological horror to challenge what we know about the products we buy, wear, and eat.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

New research on the gut-brain axis and smarter antibiotic use is transforming veterinary medicine, moving from theory to practice for healthier pets.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

U.S. Forest Service Chief Tom Schultz and the Arbor Day Foundation discuss tackling the wildfire crisis and the power of partnership in restoring America's forests.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Forty dogs, rescued from a horrific cruelty case and a unique prison program, begin their long road to recovery with Animal Rescue Corps in Tennessee.

Brazil's new antimicrobial rules are shaking up the livestock industry. See how Phibro is pivoting from growth promotion to a digital, therapeutic future.

National Veterinary Associates' new CFO has a history of IPOs and mega-deals, a clear sign the pet care giant is preparing for its public market debut.

With a new CEO known for driving massive sales growth, the microbial tech firm is poised to turn its unique animal-native science into market dominance.

Vets face a silent crisis of burnout and undervaluation. A new national campaign empowers pet owners to offer a lifeline of support and recognition.